User login
Novel and Emerging Treatments for Adult ADHD: The Path From Inception to Implementation
2022 Rare Neurological Disease Special Report
INTRODUCTION
Editor’s note
By Glenn S. Williams
Our 7th annual issue highlights several notable FDA approvals in 2021 and early 2022, emerging genetic therapies for monogenetic disorders, and recent advances in rare disease diagnosis and testing.
A note from NORD
By Peter L. Saltonstall
As we approach NORD’s 40th anniversary, it is astonishing to realize how far we all have come since the early 1980s, when rare disease patients and their medical providers were essentially on their own to navigate the challenging waters of rare disease diagnosis and treatment.
CLINICAL REVIEWS
Health care providers should have higher suspicion for rare diseases
By Jeff Craven
Learning to recognize when a cluster of symptoms doesn’t fit a pattern is important, as patients and their providers tend to gravitate toward diagnoses they are used to seeing, rather than suspecting a disease outside a usual pattern.
The paradox of Pompe disease
By Jennie Smith
For nearly 2 decades, patients with even the most severe genetic mutations have been surviving on therapy. But clinicians must now contend with previously unknown manifestations of this rare muscular disease.
Rett syndrome: Looking to the future and the promise of gene therapy
By Courtney S. Ambrose and Barbara J. Bailus, PhD
Like many monogenic disorders, Rett syndrome is entering an exciting stage – at which the words “treatment” and “cure” can be spoken with intent and conviction, not just hopeful optimism.
Rare disease patient advocacy groups empowered by data
By Theodore Bosworth
On the IAMRARE platform, patient advocacy organizations are trained to conduct observational research and host natural history.
Myasthenia gravis: Finding strength in treatment options
By Peter van der Eb; Scarlet Toruno, MS; and Jason Laird, DMSc, MHS, MBA, PA-C
Although the treatment of myasthenia gravis might have once been considered stagnant, newer expert consensus and novel research are generating optimism for innovative therapies.
Spinal muscular atrophy: Patient care in the age of genetically targeted therapy
By Kelli Whitlock Burton
Newly available treatments have changed the natural history of SMA. Newborn screening, updated treatment guidelines, and treatment algorithms have likewise changed what can be clinically done for patients with SMA, but still questions remain.
The broad and challenging – but promising – landscape of peripheral neuropathy
By Yun Seo Lee; Jonathan Kosacki; Kanika Bhandari, PharmD; Amanda Tran, PharmD
This review of peripheral neuropathy summarizes the more common causative entities, diagnostic tools that can potentially be employed to identify the disorder, and treatments that are in use or being tested to prevent, slow, or reverse its effects.
NORD Rare Disease Centers of Excellence: A new network seeks to break down barriers in rare disease care
By Jennie Smith
“The goal was to find places that could help with unanswered questions, whether diagnostic questions or treatment questions. To identify places where a patient could reasonably expect to go and have a deeper dive – maybe an interdisciplinary deep dive.”
Staying alert for patients with narcolepsy
By Erik Greb
The chronic neurologic disorder entails not only excessive sleepiness but also social and professional challenges.
ONLINE-ONLY CONTENT
Novel gene-based therapies for neuromuscular diseases
By Nahomi Yewhalashet, MBS, and Larry J. Davis, PharmD
Novel gene-based therapies show significant potential for transforming the treatment of neuromuscular diseases such as amyotrophic lateral sclerosis, spinal muscular atrophy, and Duchenne muscular dystrophy.
The urgent need to diagnose Sanfilippo syndrome at an early age
By Theodore Bosworth
The quest for effective treatments is dependent on enrolling more children at a very young age, before loss of milestones.
INTRODUCTION
Editor’s note
By Glenn S. Williams
Our 7th annual issue highlights several notable FDA approvals in 2021 and early 2022, emerging genetic therapies for monogenetic disorders, and recent advances in rare disease diagnosis and testing.
A note from NORD
By Peter L. Saltonstall
As we approach NORD’s 40th anniversary, it is astonishing to realize how far we all have come since the early 1980s, when rare disease patients and their medical providers were essentially on their own to navigate the challenging waters of rare disease diagnosis and treatment.
CLINICAL REVIEWS
Health care providers should have higher suspicion for rare diseases
By Jeff Craven
Learning to recognize when a cluster of symptoms doesn’t fit a pattern is important, as patients and their providers tend to gravitate toward diagnoses they are used to seeing, rather than suspecting a disease outside a usual pattern.
The paradox of Pompe disease
By Jennie Smith
For nearly 2 decades, patients with even the most severe genetic mutations have been surviving on therapy. But clinicians must now contend with previously unknown manifestations of this rare muscular disease.
Rett syndrome: Looking to the future and the promise of gene therapy
By Courtney S. Ambrose and Barbara J. Bailus, PhD
Like many monogenic disorders, Rett syndrome is entering an exciting stage – at which the words “treatment” and “cure” can be spoken with intent and conviction, not just hopeful optimism.
Rare disease patient advocacy groups empowered by data
By Theodore Bosworth
On the IAMRARE platform, patient advocacy organizations are trained to conduct observational research and host natural history.
Myasthenia gravis: Finding strength in treatment options
By Peter van der Eb; Scarlet Toruno, MS; and Jason Laird, DMSc, MHS, MBA, PA-C
Although the treatment of myasthenia gravis might have once been considered stagnant, newer expert consensus and novel research are generating optimism for innovative therapies.
Spinal muscular atrophy: Patient care in the age of genetically targeted therapy
By Kelli Whitlock Burton
Newly available treatments have changed the natural history of SMA. Newborn screening, updated treatment guidelines, and treatment algorithms have likewise changed what can be clinically done for patients with SMA, but still questions remain.
The broad and challenging – but promising – landscape of peripheral neuropathy
By Yun Seo Lee; Jonathan Kosacki; Kanika Bhandari, PharmD; Amanda Tran, PharmD
This review of peripheral neuropathy summarizes the more common causative entities, diagnostic tools that can potentially be employed to identify the disorder, and treatments that are in use or being tested to prevent, slow, or reverse its effects.
NORD Rare Disease Centers of Excellence: A new network seeks to break down barriers in rare disease care
By Jennie Smith
“The goal was to find places that could help with unanswered questions, whether diagnostic questions or treatment questions. To identify places where a patient could reasonably expect to go and have a deeper dive – maybe an interdisciplinary deep dive.”
Staying alert for patients with narcolepsy
By Erik Greb
The chronic neurologic disorder entails not only excessive sleepiness but also social and professional challenges.
ONLINE-ONLY CONTENT
Novel gene-based therapies for neuromuscular diseases
By Nahomi Yewhalashet, MBS, and Larry J. Davis, PharmD
Novel gene-based therapies show significant potential for transforming the treatment of neuromuscular diseases such as amyotrophic lateral sclerosis, spinal muscular atrophy, and Duchenne muscular dystrophy.
The urgent need to diagnose Sanfilippo syndrome at an early age
By Theodore Bosworth
The quest for effective treatments is dependent on enrolling more children at a very young age, before loss of milestones.
INTRODUCTION
Editor’s note
By Glenn S. Williams
Our 7th annual issue highlights several notable FDA approvals in 2021 and early 2022, emerging genetic therapies for monogenetic disorders, and recent advances in rare disease diagnosis and testing.
A note from NORD
By Peter L. Saltonstall
As we approach NORD’s 40th anniversary, it is astonishing to realize how far we all have come since the early 1980s, when rare disease patients and their medical providers were essentially on their own to navigate the challenging waters of rare disease diagnosis and treatment.
CLINICAL REVIEWS
Health care providers should have higher suspicion for rare diseases
By Jeff Craven
Learning to recognize when a cluster of symptoms doesn’t fit a pattern is important, as patients and their providers tend to gravitate toward diagnoses they are used to seeing, rather than suspecting a disease outside a usual pattern.
The paradox of Pompe disease
By Jennie Smith
For nearly 2 decades, patients with even the most severe genetic mutations have been surviving on therapy. But clinicians must now contend with previously unknown manifestations of this rare muscular disease.
Rett syndrome: Looking to the future and the promise of gene therapy
By Courtney S. Ambrose and Barbara J. Bailus, PhD
Like many monogenic disorders, Rett syndrome is entering an exciting stage – at which the words “treatment” and “cure” can be spoken with intent and conviction, not just hopeful optimism.
Rare disease patient advocacy groups empowered by data
By Theodore Bosworth
On the IAMRARE platform, patient advocacy organizations are trained to conduct observational research and host natural history.
Myasthenia gravis: Finding strength in treatment options
By Peter van der Eb; Scarlet Toruno, MS; and Jason Laird, DMSc, MHS, MBA, PA-C
Although the treatment of myasthenia gravis might have once been considered stagnant, newer expert consensus and novel research are generating optimism for innovative therapies.
Spinal muscular atrophy: Patient care in the age of genetically targeted therapy
By Kelli Whitlock Burton
Newly available treatments have changed the natural history of SMA. Newborn screening, updated treatment guidelines, and treatment algorithms have likewise changed what can be clinically done for patients with SMA, but still questions remain.
The broad and challenging – but promising – landscape of peripheral neuropathy
By Yun Seo Lee; Jonathan Kosacki; Kanika Bhandari, PharmD; Amanda Tran, PharmD
This review of peripheral neuropathy summarizes the more common causative entities, diagnostic tools that can potentially be employed to identify the disorder, and treatments that are in use or being tested to prevent, slow, or reverse its effects.
NORD Rare Disease Centers of Excellence: A new network seeks to break down barriers in rare disease care
By Jennie Smith
“The goal was to find places that could help with unanswered questions, whether diagnostic questions or treatment questions. To identify places where a patient could reasonably expect to go and have a deeper dive – maybe an interdisciplinary deep dive.”
Staying alert for patients with narcolepsy
By Erik Greb
The chronic neurologic disorder entails not only excessive sleepiness but also social and professional challenges.
ONLINE-ONLY CONTENT
Novel gene-based therapies for neuromuscular diseases
By Nahomi Yewhalashet, MBS, and Larry J. Davis, PharmD
Novel gene-based therapies show significant potential for transforming the treatment of neuromuscular diseases such as amyotrophic lateral sclerosis, spinal muscular atrophy, and Duchenne muscular dystrophy.
The urgent need to diagnose Sanfilippo syndrome at an early age
By Theodore Bosworth
The quest for effective treatments is dependent on enrolling more children at a very young age, before loss of milestones.
Pulmonology Data Trends 2022
CHEST Physician presents the 2022 edition of Pulmonology Data Trends (click to view the digital edition). This special issue provides updates on hot topics in pulmonology through original infographics and visual storytelling.
Inside this issue:
- Comorbidities, Racial Disparities, and Geographic Differences in Asthma
Navitha Ramesh, MD, FCCP - Post-COVID-19 Effects
Viren Kaul, MD, FCCP, FACP - New Pathogens, COVID-19, and Antibiotic Resistance in the Field of Pneumonia
Marcos I. Restrepo, MD, MSc, PhD, FCCP - COPD Characteristics and Health Disparities
Muhammad Adrish, MD, MBA, FCCP - Reducing Tuberculosis Globally and the Impact of COVID-19
Patricio Escalante, MD, MSc, FCCP and Paige K. Marty, MD - New Treatment Pathways for Cystic Fibrosis
David Finklea, MD - Risk Assessment in Pulmonary Arterial Hypertension
Sandeep Sahay, MD, MSc, FCCP, ATSF - Rising Incidence of Bronchiectasis and Associated Burdens
Anne E. O'Donnell, MD, FCCP - ILD: Diagnostic Considerations and Socioeconomic Barriers
Daniel Dilling, MD, FCCP, FACP, FAST - Advances in Lung Cancer Diagnostics and Treatment
Eric S. Edell, MD, FCCP
CHEST Physician presents the 2022 edition of Pulmonology Data Trends (click to view the digital edition). This special issue provides updates on hot topics in pulmonology through original infographics and visual storytelling.
Inside this issue:
- Comorbidities, Racial Disparities, and Geographic Differences in Asthma
Navitha Ramesh, MD, FCCP - Post-COVID-19 Effects
Viren Kaul, MD, FCCP, FACP - New Pathogens, COVID-19, and Antibiotic Resistance in the Field of Pneumonia
Marcos I. Restrepo, MD, MSc, PhD, FCCP - COPD Characteristics and Health Disparities
Muhammad Adrish, MD, MBA, FCCP - Reducing Tuberculosis Globally and the Impact of COVID-19
Patricio Escalante, MD, MSc, FCCP and Paige K. Marty, MD - New Treatment Pathways for Cystic Fibrosis
David Finklea, MD - Risk Assessment in Pulmonary Arterial Hypertension
Sandeep Sahay, MD, MSc, FCCP, ATSF - Rising Incidence of Bronchiectasis and Associated Burdens
Anne E. O'Donnell, MD, FCCP - ILD: Diagnostic Considerations and Socioeconomic Barriers
Daniel Dilling, MD, FCCP, FACP, FAST - Advances in Lung Cancer Diagnostics and Treatment
Eric S. Edell, MD, FCCP
CHEST Physician presents the 2022 edition of Pulmonology Data Trends (click to view the digital edition). This special issue provides updates on hot topics in pulmonology through original infographics and visual storytelling.
Inside this issue:
- Comorbidities, Racial Disparities, and Geographic Differences in Asthma
Navitha Ramesh, MD, FCCP - Post-COVID-19 Effects
Viren Kaul, MD, FCCP, FACP - New Pathogens, COVID-19, and Antibiotic Resistance in the Field of Pneumonia
Marcos I. Restrepo, MD, MSc, PhD, FCCP - COPD Characteristics and Health Disparities
Muhammad Adrish, MD, MBA, FCCP - Reducing Tuberculosis Globally and the Impact of COVID-19
Patricio Escalante, MD, MSc, FCCP and Paige K. Marty, MD - New Treatment Pathways for Cystic Fibrosis
David Finklea, MD - Risk Assessment in Pulmonary Arterial Hypertension
Sandeep Sahay, MD, MSc, FCCP, ATSF - Rising Incidence of Bronchiectasis and Associated Burdens
Anne E. O'Donnell, MD, FCCP - ILD: Diagnostic Considerations and Socioeconomic Barriers
Daniel Dilling, MD, FCCP, FACP, FAST - Advances in Lung Cancer Diagnostics and Treatment
Eric S. Edell, MD, FCCP
Gastroenterology Data Trends 2022
Inside this issue:
- The Impact of COVID-19 on Colorectal Cancer Screening Programs
Rachel B. Issaka, MD, MAS - Early Onset Colorectal Cancer: Trends in Incidence and Screening
Aasma Shaukat, MD, MPH, AGAF - Diversity in the Gastroenterology Workforce and its Implications for Patients
Sandra M. Quezada, MD, MS, AGAF - Trends in Surveillance and Management of Dysplasia in IBD
Joseph D. Feuerstein, MD, AGAF - Environmental Factors in IBD: Diet and Stress
Ashwin Ananthakrishnan, MBBS, MPH - Evolving Therapeutic Goals in Crohn’s Disease Management
Ryan Ungaro, MD, MS - Switching to Disposable Duodenoscopes: Risks and Rewards
Rajesh N. Keswani, MD, MS - Increasing Surveillance Programs and Expanding Treatment Options in HCC
Amit Singal, MD, MS - Achalasia Remains a Challenging Disorder for the Community Gastroenterologist
Benson T. Massey, MD
Inside this issue:
- The Impact of COVID-19 on Colorectal Cancer Screening Programs
Rachel B. Issaka, MD, MAS - Early Onset Colorectal Cancer: Trends in Incidence and Screening
Aasma Shaukat, MD, MPH, AGAF - Diversity in the Gastroenterology Workforce and its Implications for Patients
Sandra M. Quezada, MD, MS, AGAF - Trends in Surveillance and Management of Dysplasia in IBD
Joseph D. Feuerstein, MD, AGAF - Environmental Factors in IBD: Diet and Stress
Ashwin Ananthakrishnan, MBBS, MPH - Evolving Therapeutic Goals in Crohn’s Disease Management
Ryan Ungaro, MD, MS - Switching to Disposable Duodenoscopes: Risks and Rewards
Rajesh N. Keswani, MD, MS - Increasing Surveillance Programs and Expanding Treatment Options in HCC
Amit Singal, MD, MS - Achalasia Remains a Challenging Disorder for the Community Gastroenterologist
Benson T. Massey, MD
Inside this issue:
- The Impact of COVID-19 on Colorectal Cancer Screening Programs
Rachel B. Issaka, MD, MAS - Early Onset Colorectal Cancer: Trends in Incidence and Screening
Aasma Shaukat, MD, MPH, AGAF - Diversity in the Gastroenterology Workforce and its Implications for Patients
Sandra M. Quezada, MD, MS, AGAF - Trends in Surveillance and Management of Dysplasia in IBD
Joseph D. Feuerstein, MD, AGAF - Environmental Factors in IBD: Diet and Stress
Ashwin Ananthakrishnan, MBBS, MPH - Evolving Therapeutic Goals in Crohn’s Disease Management
Ryan Ungaro, MD, MS - Switching to Disposable Duodenoscopes: Risks and Rewards
Rajesh N. Keswani, MD, MS - Increasing Surveillance Programs and Expanding Treatment Options in HCC
Amit Singal, MD, MS - Achalasia Remains a Challenging Disorder for the Community Gastroenterologist
Benson T. Massey, MD
Stepping Forward With Real-Time Continuous Glucose Monitoring in the Primary Care Practice
Whose responsibility is it to bring new diabetes technologies and standards of care to patients’ attention?
Read More
Whose responsibility is it to bring new diabetes technologies and standards of care to patients’ attention?
Read More
Whose responsibility is it to bring new diabetes technologies and standards of care to patients’ attention?
Read More
Pediatric vaccines & infectious diseases, 2022
Introduction
ICYMI articles featuring 9 important developments of the past year – and COVID is still here
By Christopher J. Harrison, MD
Table of contents
Antibiotics use and vaccine antibody levels
Commentary
Emerging tick-borne pathogen has spread to state of Georgia
Commentary
WHO, UNICEF warn about increased risk of measles outbreaks
Commentary
Babies die as congenital syphilis continues a decade-long surge across the U.S.
Commentary
Meningococcal vaccine shows moderate protective effect against gonorrhea
Commentary
Adolescents are undertested for STIs
Commentary
TB treatment can be shortened for most children: Study
Commentary
Nirsevimab protects healthy infants from RSV
Commentary
Norovirus vaccine candidates employ different approaches
Commentary
Introduction
ICYMI articles featuring 9 important developments of the past year – and COVID is still here
By Christopher J. Harrison, MD
Table of contents
Antibiotics use and vaccine antibody levels
Commentary
Emerging tick-borne pathogen has spread to state of Georgia
Commentary
WHO, UNICEF warn about increased risk of measles outbreaks
Commentary
Babies die as congenital syphilis continues a decade-long surge across the U.S.
Commentary
Meningococcal vaccine shows moderate protective effect against gonorrhea
Commentary
Adolescents are undertested for STIs
Commentary
TB treatment can be shortened for most children: Study
Commentary
Nirsevimab protects healthy infants from RSV
Commentary
Norovirus vaccine candidates employ different approaches
Commentary
Introduction
ICYMI articles featuring 9 important developments of the past year – and COVID is still here
By Christopher J. Harrison, MD
Table of contents
Antibiotics use and vaccine antibody levels
Commentary
Emerging tick-borne pathogen has spread to state of Georgia
Commentary
WHO, UNICEF warn about increased risk of measles outbreaks
Commentary
Babies die as congenital syphilis continues a decade-long surge across the U.S.
Commentary
Meningococcal vaccine shows moderate protective effect against gonorrhea
Commentary
Adolescents are undertested for STIs
Commentary
TB treatment can be shortened for most children: Study
Commentary
Nirsevimab protects healthy infants from RSV
Commentary
Norovirus vaccine candidates employ different approaches
Commentary
Federal Health Care Data Trends 2022
Federal Health Care Data Trends (click to view the digital edition) is a special supplement to Federal Practitioner highlighting the latest research and study outcomes related to the health of veteran and active-duty populations.
In this issue:
- Vaccinations
- Mental Health and Related Disorders
- LGBTQ+ Veterans
- Military Sexual Trauma
- Sleep Disorders
- Respiratory Illnesses
- HIV Care in the VA
- Rheumatologic Diseases
- The Cancer-Obesity Connection
- Skin Health for Active-Duty Personnel
- Contraception
- Chronic Kidney Disease
- Cardiovascular Diseases
- Neurologic Disorders
- Hearing, Vision, and Balance
Federal Practitioner would like to thank the following experts for their review of content and helpful guidance in developing this issue:
Kelvin N.V. Bush, MD, FACC, CCDS; Sonya Borrero, MD, MS; Kenneth L. Cameron, PhD, MPH, ATC, FNATA; Jason DeViva, PhD; Ellen Lockard Edens, MD; Leonard E. Egede, MD, MS; Amy Justice, MD, PhD; Stephanie Knudson, MD; Willis H. Lyford, MD; Sarah O. Meadows, PhD; Tamara Schult, PhD, MPH; Eric L. Singman, MD, PhD; Art Wallace, MD, PhD; Elizabeth Waterhouse, MD, FAAN
Federal Health Care Data Trends (click to view the digital edition) is a special supplement to Federal Practitioner highlighting the latest research and study outcomes related to the health of veteran and active-duty populations.
In this issue:
- Vaccinations
- Mental Health and Related Disorders
- LGBTQ+ Veterans
- Military Sexual Trauma
- Sleep Disorders
- Respiratory Illnesses
- HIV Care in the VA
- Rheumatologic Diseases
- The Cancer-Obesity Connection
- Skin Health for Active-Duty Personnel
- Contraception
- Chronic Kidney Disease
- Cardiovascular Diseases
- Neurologic Disorders
- Hearing, Vision, and Balance
Federal Practitioner would like to thank the following experts for their review of content and helpful guidance in developing this issue:
Kelvin N.V. Bush, MD, FACC, CCDS; Sonya Borrero, MD, MS; Kenneth L. Cameron, PhD, MPH, ATC, FNATA; Jason DeViva, PhD; Ellen Lockard Edens, MD; Leonard E. Egede, MD, MS; Amy Justice, MD, PhD; Stephanie Knudson, MD; Willis H. Lyford, MD; Sarah O. Meadows, PhD; Tamara Schult, PhD, MPH; Eric L. Singman, MD, PhD; Art Wallace, MD, PhD; Elizabeth Waterhouse, MD, FAAN
Federal Health Care Data Trends (click to view the digital edition) is a special supplement to Federal Practitioner highlighting the latest research and study outcomes related to the health of veteran and active-duty populations.
In this issue:
- Vaccinations
- Mental Health and Related Disorders
- LGBTQ+ Veterans
- Military Sexual Trauma
- Sleep Disorders
- Respiratory Illnesses
- HIV Care in the VA
- Rheumatologic Diseases
- The Cancer-Obesity Connection
- Skin Health for Active-Duty Personnel
- Contraception
- Chronic Kidney Disease
- Cardiovascular Diseases
- Neurologic Disorders
- Hearing, Vision, and Balance
Federal Practitioner would like to thank the following experts for their review of content and helpful guidance in developing this issue:
Kelvin N.V. Bush, MD, FACC, CCDS; Sonya Borrero, MD, MS; Kenneth L. Cameron, PhD, MPH, ATC, FNATA; Jason DeViva, PhD; Ellen Lockard Edens, MD; Leonard E. Egede, MD, MS; Amy Justice, MD, PhD; Stephanie Knudson, MD; Willis H. Lyford, MD; Sarah O. Meadows, PhD; Tamara Schult, PhD, MPH; Eric L. Singman, MD, PhD; Art Wallace, MD, PhD; Elizabeth Waterhouse, MD, FAAN
A Special Supplement on Hot Topics in Primary Care 2022
Hot Topics in Primary Care 2022 is a resource that explores the newest developments in primary care topics that impact your daily clinical practice.
Click on the link below to access the entire supplement. You can also click on the video panes below to view brief summaries of individual chapters. Titles above the video panes link directly to each article.
- A Paradigm Shift for Asthma Care
- Common Questions on Continuous Glucose Monitoring in Primary Care
- Detecting and Managing ASCVD in Women: A Focus on Statins
- Improving Detection and Management of Anemia in CKD
- OTC Analgesics vs Opioids for Pain Management
- Practical Considerations for Use of Insulin/Glucagon-Like Peptide 1 Receptor Agonist Combinations in Older Adults With Type 2 Diabetes
- Practical Screening for Islet Autoantibodies: The Time Has Come
- Reducing Thrombotic Risk From Polyvascular Disease in Primary Care
- Strategies to Improve Outcomes in COPD
- The Evolving Landscape of ASCVD Risk Among Patients With HIV
- The New Face of Preadolescent and Adolescent Acne: Beyond the Guidelines
- The Role of Eggs in Healthy Diets
- Update on the Gut Microbiome for the Primary Care Clinician
- Updates in the Management of Mild Cognitive Impairment and Alzheimer Disease
- Use of SGLT-2 Inhibitors for Chronic Kidney Disease in Primary Care
This supplement offers the opportunity to earn a total of 4 continuing medical education (CME) credits. Credit is awarded for successful completion of the evaluation after reading the article. The links can be found within the supplement on the first page of each article where CME credits are offered.
Click here to read Hot Topics in Primary Care 2022
This supplement to The Journal of Family Practice was sponsored by the Primary Care Education Consortium and Primary Care Metabolic Group.
Check out these short video segments, which were prepared by the supplement authors and summarize the individual articles.
The title above each video links to the related article.
A Paradigm Shift for Asthma Care, Njira Lugogo, MD; Neil Skolnik, MD; Yihui Jiang, DO
Common Questions on Continuous Glucose Monitoring in Primary Care, Eden M. Miller, DO
Detecting and Managing ASCVD in Women: A Focus on Statins, Pam Kushner, MD
Improving Detection and Management of Anemia in CKD, Steven Fishbane, MD; Stephen Brunton, MD, FAAFP
OTC Analgesics vs Opioids for Pain Management, Gary M. Ruoff, MD
Practical Screening for Islet Autoantibodies: The Time Has Come, Timothy Reid, MD
Reducing Thrombotic Risk From Polyvascular Disease in Primary Care, Stephen Brunton, MD, FAAFP
Strategies to Improve Outcomes in COPD, Barbara Yawn, MD, MSc, FAAFP
The Evolving Landscape of ASCVD Risk Among Patients With HIV, Carlos Malvestutto, MD, MPH
The Role of Eggs in Healthy Diets, Maria Luz Fernandez, PhD
Update on the Gut Microbiome for the Primary Care Clinician, Eden M. Miller, DO
Updates in the Management of Mild Cognitive Impairment and Alzheimer Disease, Gary Small, MD
Use of SGLT-2 Inhibitors for Chronic Kidney Disease in Primary Care, George Bakris, MD
Hot Topics in Primary Care 2022 is a resource that explores the newest developments in primary care topics that impact your daily clinical practice.
Click on the link below to access the entire supplement. You can also click on the video panes below to view brief summaries of individual chapters. Titles above the video panes link directly to each article.
- A Paradigm Shift for Asthma Care
- Common Questions on Continuous Glucose Monitoring in Primary Care
- Detecting and Managing ASCVD in Women: A Focus on Statins
- Improving Detection and Management of Anemia in CKD
- OTC Analgesics vs Opioids for Pain Management
- Practical Considerations for Use of Insulin/Glucagon-Like Peptide 1 Receptor Agonist Combinations in Older Adults With Type 2 Diabetes
- Practical Screening for Islet Autoantibodies: The Time Has Come
- Reducing Thrombotic Risk From Polyvascular Disease in Primary Care
- Strategies to Improve Outcomes in COPD
- The Evolving Landscape of ASCVD Risk Among Patients With HIV
- The New Face of Preadolescent and Adolescent Acne: Beyond the Guidelines
- The Role of Eggs in Healthy Diets
- Update on the Gut Microbiome for the Primary Care Clinician
- Updates in the Management of Mild Cognitive Impairment and Alzheimer Disease
- Use of SGLT-2 Inhibitors for Chronic Kidney Disease in Primary Care
This supplement offers the opportunity to earn a total of 4 continuing medical education (CME) credits. Credit is awarded for successful completion of the evaluation after reading the article. The links can be found within the supplement on the first page of each article where CME credits are offered.
Click here to read Hot Topics in Primary Care 2022
This supplement to The Journal of Family Practice was sponsored by the Primary Care Education Consortium and Primary Care Metabolic Group.
Check out these short video segments, which were prepared by the supplement authors and summarize the individual articles.
The title above each video links to the related article.
A Paradigm Shift for Asthma Care, Njira Lugogo, MD; Neil Skolnik, MD; Yihui Jiang, DO
Common Questions on Continuous Glucose Monitoring in Primary Care, Eden M. Miller, DO
Detecting and Managing ASCVD in Women: A Focus on Statins, Pam Kushner, MD
Improving Detection and Management of Anemia in CKD, Steven Fishbane, MD; Stephen Brunton, MD, FAAFP
OTC Analgesics vs Opioids for Pain Management, Gary M. Ruoff, MD
Practical Screening for Islet Autoantibodies: The Time Has Come, Timothy Reid, MD
Reducing Thrombotic Risk From Polyvascular Disease in Primary Care, Stephen Brunton, MD, FAAFP
Strategies to Improve Outcomes in COPD, Barbara Yawn, MD, MSc, FAAFP
The Evolving Landscape of ASCVD Risk Among Patients With HIV, Carlos Malvestutto, MD, MPH
The Role of Eggs in Healthy Diets, Maria Luz Fernandez, PhD
Update on the Gut Microbiome for the Primary Care Clinician, Eden M. Miller, DO
Updates in the Management of Mild Cognitive Impairment and Alzheimer Disease, Gary Small, MD
Use of SGLT-2 Inhibitors for Chronic Kidney Disease in Primary Care, George Bakris, MD
Hot Topics in Primary Care 2022 is a resource that explores the newest developments in primary care topics that impact your daily clinical practice.
Click on the link below to access the entire supplement. You can also click on the video panes below to view brief summaries of individual chapters. Titles above the video panes link directly to each article.
- A Paradigm Shift for Asthma Care
- Common Questions on Continuous Glucose Monitoring in Primary Care
- Detecting and Managing ASCVD in Women: A Focus on Statins
- Improving Detection and Management of Anemia in CKD
- OTC Analgesics vs Opioids for Pain Management
- Practical Considerations for Use of Insulin/Glucagon-Like Peptide 1 Receptor Agonist Combinations in Older Adults With Type 2 Diabetes
- Practical Screening for Islet Autoantibodies: The Time Has Come
- Reducing Thrombotic Risk From Polyvascular Disease in Primary Care
- Strategies to Improve Outcomes in COPD
- The Evolving Landscape of ASCVD Risk Among Patients With HIV
- The New Face of Preadolescent and Adolescent Acne: Beyond the Guidelines
- The Role of Eggs in Healthy Diets
- Update on the Gut Microbiome for the Primary Care Clinician
- Updates in the Management of Mild Cognitive Impairment and Alzheimer Disease
- Use of SGLT-2 Inhibitors for Chronic Kidney Disease in Primary Care
This supplement offers the opportunity to earn a total of 4 continuing medical education (CME) credits. Credit is awarded for successful completion of the evaluation after reading the article. The links can be found within the supplement on the first page of each article where CME credits are offered.
Click here to read Hot Topics in Primary Care 2022
This supplement to The Journal of Family Practice was sponsored by the Primary Care Education Consortium and Primary Care Metabolic Group.
Check out these short video segments, which were prepared by the supplement authors and summarize the individual articles.
The title above each video links to the related article.
A Paradigm Shift for Asthma Care, Njira Lugogo, MD; Neil Skolnik, MD; Yihui Jiang, DO
Common Questions on Continuous Glucose Monitoring in Primary Care, Eden M. Miller, DO
Detecting and Managing ASCVD in Women: A Focus on Statins, Pam Kushner, MD
Improving Detection and Management of Anemia in CKD, Steven Fishbane, MD; Stephen Brunton, MD, FAAFP
OTC Analgesics vs Opioids for Pain Management, Gary M. Ruoff, MD
Practical Screening for Islet Autoantibodies: The Time Has Come, Timothy Reid, MD
Reducing Thrombotic Risk From Polyvascular Disease in Primary Care, Stephen Brunton, MD, FAAFP
Strategies to Improve Outcomes in COPD, Barbara Yawn, MD, MSc, FAAFP
The Evolving Landscape of ASCVD Risk Among Patients With HIV, Carlos Malvestutto, MD, MPH
The Role of Eggs in Healthy Diets, Maria Luz Fernandez, PhD
Update on the Gut Microbiome for the Primary Care Clinician, Eden M. Miller, DO
Updates in the Management of Mild Cognitive Impairment and Alzheimer Disease, Gary Small, MD
Use of SGLT-2 Inhibitors for Chronic Kidney Disease in Primary Care, George Bakris, MD
Omadacycline: An Oral Antibiotic for the Treatment of Bacterial Skin Infections and Pneumonia in an Era of Unmet Clinical Need
Read More
Read More
Read More
Advances In Neurologic Care
- Pharmacist Impact on Access to Care in an Epilepsy Clinic
- MRI Protocols for Veterans With Multiple Sclerosis
- Neuroimaging in the Era of Artificial Intelligence
- Autonomic Dysfunction in CADASIL Syndrome
- Pharmacist Impact on Access to Care in an Epilepsy Clinic
- MRI Protocols for Veterans With Multiple Sclerosis
- Neuroimaging in the Era of Artificial Intelligence
- Autonomic Dysfunction in CADASIL Syndrome
- Pharmacist Impact on Access to Care in an Epilepsy Clinic
- MRI Protocols for Veterans With Multiple Sclerosis
- Neuroimaging in the Era of Artificial Intelligence
- Autonomic Dysfunction in CADASIL Syndrome